Description

Twinrix (Hepatitis A, B Virus) Suspension for Injections 1 ml Syringe №1

Ingredients:

Each 1 ml syringe of Twinrix contains inactivated hepatitis A virus (strain HM175) and recombinant hepatitis B surface antigen.

Dosage:

The standard dosage is 1 ml injected intramuscularly at 0, 1, and 6 months. Consult a healthcare provider for personalized dosing.

Indications:

Twinrix is indicated for active immunization against hepatitis A and B in individuals aged 18 years and older. It helps prevent infection by stimulating the immune system to produce antibodies.

Contraindications:

Do not use Twinrix if you have had a severe allergic reaction to any component of the vaccine or after a previous dose of Twinrix. Consult your healthcare provider for guidance.

Directions:

Administer Twinrix via intramuscular injection into the deltoid muscle. Follow the recommended dosing schedule for optimal protection against hepatitis A and B viruses.

Scientific Evidence:

Studies have shown that Twinrix is highly effective in inducing protective antibody levels against hepatitis A and B viruses. Research published in the Journal of Viral Hepatitis demonstrated the vaccine’s long-term immunogenicity and safety profile.

Additional Information:

Twinrix combines the benefits of hepatitis A and B vaccines in a single injection, simplifying the immunization process for at-risk individuals. It provides a convenient and cost-effective solution for dual protection.

Pharmacological Effects: Twinrix works by stimulating the immune system to produce antibodies against hepatitis A and B viruses. The inactivated hepatitis A virus and recombinant hepatitis B surface antigen trigger an immune response, providing immunity against future infections.

Clinical Trials: Clinical trials have demonstrated the efficacy and safety of Twinrix in preventing hepatitis A and B infections. A study published in Vaccine showed high seroprotection rates following vaccination with Twinrix, highlighting its effectiveness in providing immunity.